VUNO Inc., South Korean artificial intelligence (AI) developer is showcasing its solutions at the European Congress of Radiology 2020 (ECR 2020) to be held from July 15 to July 19, 2020. The company aims at showcasing the power of its flagship AI radiology solutions that have recently received the CE mark. 

VUNO's exhibition at the event will include VUNO Med^®–LungCT AI™ that detects, locates, and quantifies pulmonary lung nodules on CT images, VUNO Med^®-Chest X-Ray™ that assists in the chest X-ray readings of common thoracic abnormalities on chest radiographs. VUNO Med^®-DeepBrain™ is a diagnostic supporting tool for degenerative brain diseases through brain parcellation & quantification on brain MR images.

On top of the three solutions to be showcased at this event, VUNO has two other solutions that have gained CE certifications recently - VUNO Med^®-BoneAge™ and VUNO Med^® – Fundus AI. All these five products are now available to be marketed in countries where CE marking is acceptable.

VUNO Med^® solutions are designed to be agnostic to any devices and any environments offering seamless integration with any PACS and/or EMR systems. They are offered via cloud servers allowing users to analyze images anytime, anywhere with access to the Internet. They are also available through on-premise installations as well. 

As part of its ambitious plan to go global, VUNO is set to seize this opportunity to further expand its networks with sales prospects and business partners from all around the world.